Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (51 ops.)
Latest filing published 09 Mar 2026 for Teva Pharmaceutical Industries Ltd, €471k.
Filing timeline
BuySaleRichard Daniell
Insider track record
Disclosed buys
0
Disclosed sells
51
Signal history
Richard Daniell: trading record in brief
Richard Daniell is Exec. VP, European Commercial of Teva Pharmaceutical Industries Ltd, the only company in a record of 98 filings published from March 6, 2018 to March 9, 2026. Volume is stable, from 8 to 11 filings a year, with a peak of 18 in 2025.
Option exercises dominate: 45 filings, against 51 open-market sales and 2 share grants. The sales total EUR 20,135,514, with a median of EUR 184,861. The three largest are EUR 2,844,684 on December 9, 2025, then EUR 1,846,195 and EUR 1,722,119, both on March 3, 2026. No purchase is on record.
Over the last twelve months, 14 filings are recorded, 7 of them sales. They are published a median of 2 days after the trade.
At Teva, Mark Sabag has 29 trades within 30 days of Daniell's, Sven Dethlefs 24, David Matthew Stark 23, and Eric A. Hughes and Eric Drape 22 each, always in the same direction.
Companies and markets linked to Richard Daniell
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations98 total
17,295 shares@ US$31.672.1% of flowOrdinary SharesSEC:0001193125-26-098512:1
17,295 sharesOrdinary SharesSEC:0001193125-26-098512:0
20,461 sharesOrdinary SharesSEC:0001193125-26-096584:2
33,512 shares@ US$32.464.3% of flowOrdinary SharesSEC:0001193125-26-096584:1
20,461 shares@ US$32.462.6% of flowOrdinary SharesSEC:0001193125-26-096584:3
37,372 shares@ US$32.954.8% of flowOrdinary SharesSEC:0001193125-26-096584:4
33,512 sharesOrdinary SharesSEC:0001193125-26-096584:0
141,478 sharesOrdinary SharesSEC:0001193125-26-093945:2
62,250 shares@ US$32.367.8% of flowOrdinary SharesSEC:0001193125-26-093945:1
66,735 shares@ US$32.368.4% of flowOrdinary SharesSEC:0001193125-26-093945:3
62,250 sharesOrdinary SharesSEC:0001193125-26-093945:0
15,011 shares@ US$16.991.0% of flowOrdinary SharesSEC:0001193125-25-315938:1
115,468 shares@ US$28.6812.9% of flowOrdinary SharesSEC:0001193125-25-315938:2
100,457 shares@ US$18.6148.1% of flowOrdinary SharesSEC:0001193125-25-315938:0
22,576 shares@ US$15.911.5% of flowOrdinary SharesSEC:0000950170-25-035489:1
48,385 shares@ US$15.903.3% of flowOrdinary SharesSEC:0000950170-25-035489:2
22,576 sharesOrdinary SharesSEC:0000950170-25-035489:0
20,461 sharesOrdinary SharesSEC:0000950170-25-034607:3
183,169 sharesOrdinary SharesSEC:0000950170-25-034607:6
21,870 shares@ US$15.731.5% of flowOrdinary SharesSEC:0000950170-25-034607:1
11,641 shares@ US$15.910.8% of flowOrdinary SharesSEC:0000950170-25-034607:2
13,353 shares@ US$15.730.9% of flowOrdinary SharesSEC:0000950170-25-034607:4
7,108 shares@ US$15.910.5% of flowOrdinary SharesSEC:0000950170-25-034607:5
56,385 shares@ US$15.733.8% of flowOrdinary SharesSEC:0000950170-25-034607:7
30,015 shares@ US$15.912.0% of flowOrdinary SharesSEC:0000950170-25-034607:8
25 of 98 declarations
